Yuzwa, S. A., Shan, X., Jones, B. A., Zhao, G., Woodward, M. L., Li, X., . . . Vocadlo, D. J. (2014). Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice. Mol Neurodegener.
Chicago Style CitationYuzwa, Scott A., et al. "Pharmacological Inhibition of O-GlcNAcase (OGA) Prevents Cognitive Decline and Amyloid Plaque Formation in Bigenic Tau/APP Mutant Mice." Mol Neurodegener 2014.
Cita MLAYuzwa, Scott A., et al. "Pharmacological Inhibition of O-GlcNAcase (OGA) Prevents Cognitive Decline and Amyloid Plaque Formation in Bigenic Tau/APP Mutant Mice." Mol Neurodegener 2014.
Atenció: Aquestes cites poden no estar 100% correctes.